ASND ▼ -0.2% - Ascendis Pharma A/S $ASND - Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE 2026 Ascendis Pharma fell 0.2% today after announcing it will present endocrinology rare disease data at the ESPE 2026 conference. The modest decline suggests investors may have been hoping for more immediate clinical results or regulatory updates rather than a future presentation schedule. 07-SEP-2026 07:00 AM ET